Semi-Annual Statement Of Cash Flows

Kringle Pharma,Inc. - Filing #7609492

Concept 2021-10-01 to
2022-03-31
As at
2022-03-31
As at
2021-09-30
2020-10-01 to
2021-03-31
As at
2021-03-31
As at
2020-09-30
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-318,965,000 JPY
-191,777,000 JPY
Interest and dividend income
0 JPY
0 JPY
Decrease (increase) in trade receivables
6,717,000 JPY
105,810,000 JPY
Decrease (increase) in inventories
-111,333,000 JPY
-174,533,000 JPY
Other, net
1,973,000 JPY
7,380,000 JPY
Subtotal
-196,509,000 JPY
-314,413,000 JPY
Interest and dividends received
0 JPY
0 JPY
Income taxes paid
-1,490,000 JPY
-1,490,000 JPY
Net cash provided by (used in) operating activities
-150,244,000 JPY
-268,903,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-254,374,000 JPY
JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
608,592,000 JPY
Net cash provided by (used in) financing activities
386,264,000 JPY
597,026,000 JPY
Other, net
-30,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-18,354,000 JPY
328,123,000 JPY
Cash and cash equivalents
2,119,165,000 JPY
2,137,520,000 JPY
2,430,662,000 JPY
2,102,538,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.